碘仿氢氧化钙与化学氢氧碘仿氢氧化钙盖髓治疗对可复性牙髓炎患者疗效对比分析
|
摘要
目的比较碘仿氢氧化钙与化学氢氧化钙盖髓应用在可复性牙髓炎中的临床疗效。方法选择该院2015年9月—2016年3月期间所收治的100例可复性牙髓炎患者作为该次研究病例,按照治疗方法的不同将其分为研究组和对照组,每组50例,研究组应用碘仿氢氧化钙盖髓治疗,对照组应用化学氢氧化钙盖髓治疗,比较两组患者的治疗效果,疼痛症状评分与不良反应发生情况。结果研究组可复性牙髓炎患者治疗总有效率(94.00%)显著高于对照组(78.00%),组间比较差异有统计学意义(χ~2=5.315 6,P<0.05);研究组可复性牙髓炎患者疼痛症状评分为(0.3±0.1)分,对照组为(1.2±0.3)分,组间比较差异有统计学意义(t=20.124 6,P<0.05);研究组可复性牙髓炎患者不良反应发生率为4.00%,对照组不良反应发生率为18.00%,组间比较差异有统计学意义(χ~2=5.005 1,P<0.05)。结论碘仿氢氧化钙盖髓治疗可复性牙髓炎的效果明显,不良反应少,安全性高,值得临床应用。
Objective To compare the clinical efficacy of iodoform calcium hydroxide and chemical calcium hydroxide capping pulp in reversible pulpitis. Methods A total of 100 patients with reversible pulpitis treated in the hospital from September 2015 to March 2016 were selected as the study case. According to different treatment methods, they were divided into study group and control group. In 50 cases, the study group was treated with iodoform calcium hydroxide capping pulp, and the control group was treated with chemical calcium hydroxide capping pulp. The treatment effects,pain symptom scores, and incidence of adverse reactions were compared between the two groups of patients. Results The total effective rate of treatment in patients with reversible pulpitis(94.00%) was significantly higher in the study group than in the control group(78.00%). There was significant difference between the two groups (χ~2=5.315 6,P<0.05);The score of pain symptom in patients with reversible pulpitis was(0.3±0.1) points, and that of the control group was (1.2 ±0.3) points. There was statistically significant difference between the two groups (t =20.124 6,P <0.05); the reversibility of the study group incidence of adverse reactions in patients with pulpitis was 4.00%. The incidence of adverse reactions in the control group was 18.00%. There was a statistically significant difference between groups (P<0.05,χ~2=5.005 1). Conclusion Iodoform calcium hydroxide capping pulp has obvious effect on reversible pulpitis, with fewer adverse reactions and high safety. It is worthy of clinical application.
Objective To compare the clinical efficacy of iodoform calcium hydroxide and chemical calcium hydroxide capping pulp in reversible pulpitis. Methods A total of 100 patients with reversible pulpitis treated in the hospital from September 2015 to March 2016 were selected as the study case. According to different treatment methods, they were divided into study group and control group. In 50 cases, the study group was treated with iodoform calcium hydroxide capping pulp, and the control group was treated with chemical calcium hydroxide capping pulp. The treatment effects,pain symptom scores, and incidence of adverse reactions were compared between the two groups of patients. Results The total effective rate of treatment in patients with reversible pulpitis(94.00%) was significantly higher in the study group than in the control group(78.00%). There was significant difference between the two groups (χ~2=5.315 6,P<0.05);The score of pain symptom in patients with reversible pulpitis was(0.3±0.1) points, and that of the control group was (1.2 ±0.3) points. There was statistically significant difference between the two groups (t =20.124 6,P <0.05); the reversibility of the study group incidence of adverse reactions in patients with pulpitis was 4.00%. The incidence of adverse reactions in the control group was 18.00%. There was a statistically significant difference between groups (P<0.05,χ~2=5.005 1). Conclusion Iodoform calcium hydroxide capping pulp has obvious effect on reversible pulpitis, with fewer adverse reactions and high safety. It is worthy of clinical application.
引文
[1]谷春妍,黄震.氢氧化钙糊剂联合根管治疗术治疗牙髓炎或根尖炎的临床疗效[J].中国生化药物杂志,2016,36(6):79-81.
[2]赵新宇.用两种盖髓剂对可复性牙髓炎患者进行盖髓治疗的效果对比[J].当代医药论丛,2015(15):238-239.
[3]陈静.氢氧化钙糊剂活髓保存治疗龋源性牙髓炎的疗效探讨[J].中外医疗,2014(25):135-136.
[4]陈苏杨,薄锋.MTA与碘仿氢氧化钙糊剂盖髓治疗可复性牙髓炎的临床观察[J].中国医药指南,2014(10):193-194.
[5]牛小珍,牛晓成.龋源性牙髓炎患者治疗中氢氧化钙糊剂活髓保存的效果[J].养生保健指南,2017(8):302.
[6]刘家林.氢氧化钙治疗46例恒磨牙牙髓炎的临床疗效观察[J].现代诊断与治疗,2014(5):1119-1120.
[7]阿达来提·麻合苏提,郝琦.分析氢氧化钙糊剂活髓保存在龋源性牙髓炎患者的疗效[J].全科口腔医学电子杂志,2016(1):148,150.
[8]胡冰.分析氢氧化钙糊剂活髓保存在龋源性牙髓炎患者治疗中的临床效果[J].全科口腔医学电子杂志,2016(17):34,36.
[9]魏建敏,谷珊瑚,孙建伟,等.曲安奈德-氢氧化钙碘仿糊剂对一次法根管治疗后镇痛效果评价[J].广西医学,2016,38(7):1010-1012.
[10]陈小贤,林碧琛,钟洁,等.改良乳牙根管充填材料体内降解匹配性与临床效果[J].北京大学学报:医学版,2015(3):529-535.
[11]孙德刚,吴迪,郭吉来,等.氢氧化钙糊剂用于治疗约诊间疼痛的临床观察[J].口腔医学,2015,35(2):138-140.
[12]高燕.氢氧化钙碘仿糊剂在儿童根管治疗中的应用效果[J].全科口腔医学电子杂志,2017,4(12):46-47.
[13]曹丽芳.氢氧化钙糊剂联合根管治疗术治疗牙髓炎或根尖炎的临床效果观察[J].临床合理用药杂志,2018,11(5):148-149.
[14]杨涛.氢氧化钙糊剂联合根管治疗术治疗牙髓炎临床分析[J].系统医学,2017,2(16):105-107.
[15]赵芙蓉.氢氧化钙糊剂充填根管对牙髓炎或根尖炎患者牙周指数及血清炎性因子的影响[J].医学新知杂志,2017,27(3):280-281.
[16]李剑锋.碘仿氢氧化钙糊剂盖髓对可复性牙髓炎的效果分析[J].中外医学研究,2014(32):119-120.
[2]赵新宇.用两种盖髓剂对可复性牙髓炎患者进行盖髓治疗的效果对比[J].当代医药论丛,2015(15):238-239.
[3]陈静.氢氧化钙糊剂活髓保存治疗龋源性牙髓炎的疗效探讨[J].中外医疗,2014(25):135-136.
[4]陈苏杨,薄锋.MTA与碘仿氢氧化钙糊剂盖髓治疗可复性牙髓炎的临床观察[J].中国医药指南,2014(10):193-194.
[5]牛小珍,牛晓成.龋源性牙髓炎患者治疗中氢氧化钙糊剂活髓保存的效果[J].养生保健指南,2017(8):302.
[6]刘家林.氢氧化钙治疗46例恒磨牙牙髓炎的临床疗效观察[J].现代诊断与治疗,2014(5):1119-1120.
[7]阿达来提·麻合苏提,郝琦.分析氢氧化钙糊剂活髓保存在龋源性牙髓炎患者的疗效[J].全科口腔医学电子杂志,2016(1):148,150.
[8]胡冰.分析氢氧化钙糊剂活髓保存在龋源性牙髓炎患者治疗中的临床效果[J].全科口腔医学电子杂志,2016(17):34,36.
[9]魏建敏,谷珊瑚,孙建伟,等.曲安奈德-氢氧化钙碘仿糊剂对一次法根管治疗后镇痛效果评价[J].广西医学,2016,38(7):1010-1012.
[10]陈小贤,林碧琛,钟洁,等.改良乳牙根管充填材料体内降解匹配性与临床效果[J].北京大学学报:医学版,2015(3):529-535.
[11]孙德刚,吴迪,郭吉来,等.氢氧化钙糊剂用于治疗约诊间疼痛的临床观察[J].口腔医学,2015,35(2):138-140.
[12]高燕.氢氧化钙碘仿糊剂在儿童根管治疗中的应用效果[J].全科口腔医学电子杂志,2017,4(12):46-47.
[13]曹丽芳.氢氧化钙糊剂联合根管治疗术治疗牙髓炎或根尖炎的临床效果观察[J].临床合理用药杂志,2018,11(5):148-149.
[14]杨涛.氢氧化钙糊剂联合根管治疗术治疗牙髓炎临床分析[J].系统医学,2017,2(16):105-107.
[15]赵芙蓉.氢氧化钙糊剂充填根管对牙髓炎或根尖炎患者牙周指数及血清炎性因子的影响[J].医学新知杂志,2017,27(3):280-281.
[16]李剑锋.碘仿氢氧化钙糊剂盖髓对可复性牙髓炎的效果分析[J].中外医学研究,2014(32):119-120.